These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19026704)

  • 41. Protective immunity induced by vaccination with SAG1 gene-transfected cells against Toxoplasma gondii-infection in mice.
    Aosai F; Mun HS; Norose K; Chen M; Hata H; Kobayashi M; Kiuchi M; Stauss HJ; Yano A
    Microbiol Immunol; 1999; 43(1):87-91. PubMed ID: 10100753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccination protects B cell-deficient mice against an oral challenge with mildly virulent Toxoplasma gondii.
    Johnson LL; Lanthier P; Hoffman J; Chen W
    Vaccine; 2004 Sep; 22(29-30):4054-61. PubMed ID: 15364456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune response and protective effect against chronic Toxoplasma gondii infection induced by vaccination with a DNA vaccine encoding profilin.
    Gao Q; Zhang NZ; Zhang FK; Wang M; Hu LY; Zhu XQ
    BMC Infect Dis; 2018 Mar; 18(1):117. PubMed ID: 29514647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protective immunity induced by CpG ODN-adjuvanted virus-like particles containing Toxoplasma gondii proteins.
    Kang HJ; Chu KB; Kim MJ; Lee SH; Park H; Jin H; Moon EK; Quan FS
    Parasite Immunol; 2021 Jan; 43(1):e12799. PubMed ID: 33058167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Intranasal immunization with mucosal complex vaccine protects mice against Toxoplasma gondii].
    Yin GR; Meng XL; Ma GY; Ma XM
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Aug; 25(4):290-4. PubMed ID: 18038798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii.
    Leyva R; Hérion P; Saavedra R
    Parasitol Res; 2001 Jan; 87(1):70-9. PubMed ID: 11199854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of Protective Immune Responses Induced by Recombinant TrxLp and ENO2 Proteins against
    Wang M; Yang XY; Zhang NZ; Zhang DL; Zhu XQ
    Biomed Res Int; 2016; 2016():3571962. PubMed ID: 27803923
    [No Abstract]   [Full Text] [Related]  

  • 48. Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.
    Cao A; Liu Y; Wang J; Li X; Wang S; Zhao Q; Cong H; He S; Zhou H
    Vaccine; 2015 Nov; 33(48):6757-62. PubMed ID: 26518401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
    Zheng B; Lu S; Tong Q; Kong Q; Lou D
    Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Strain- and Dose-Dependent Reduction of
    Jennes M; De Craeye S; Devriendt B; Dierick K; Dorny P; Cox E
    Front Cell Infect Microbiol; 2017; 7():232. PubMed ID: 28642841
    [No Abstract]   [Full Text] [Related]  

  • 51. Virus-like particles containing multiple antigenic proteins of Toxoplasma gondii induce memory T cell and B cell responses.
    Lee SH; Chu KB; Kang HJ; Quan FS
    PLoS One; 2019; 14(8):e0220865. PubMed ID: 31465461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of immunogenicity and protective effect of DNA vaccine encoding surface antigen1 (SAG1) of Toxoplasma gondii and TLR-5 ligand as a genetic adjuvant against acute toxoplasmosis in BALB/c mice.
    Maraghi S; Ghadiri AA; Tavalla M; Shojaee S; Abdizadeh R
    Biologicals; 2019 Nov; 62():39-49. PubMed ID: 31610951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental ocular toxoplasmosis induced in naive and preinfected mice by intracameral inoculation.
    Hu MS; Schwartzman JD; Lepage AC; Khan IA; Kasper LH
    Ocul Immunol Inflamm; 1999 Mar; 7(1):17-26. PubMed ID: 10410871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunostimulatory efficacy and protective potential of putative TgERK7 protein in mice experimentally infected by Toxoplasma gondii.
    Li ZY; Guo HT; Calderón-Mantilla G; He JJ; Wang JL; Bonev BB; Zhu XQ; Elsheikha HM
    Int J Med Microbiol; 2020 Jul; 310(5):151432. PubMed ID: 32654774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of protective immunity induced by recombinant calcium-dependent protein kinase 1 (TgCDPK1) protein against acute toxoplasmosis in mice.
    Huang SY; Chen K; Wang JL; Yang B; Zhu XQ
    Microb Pathog; 2019 Aug; 133():103560. PubMed ID: 31145981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Toxoplasma gondii rhomboid protein 1 (TgROM1) is a potential vaccine candidate against toxoplasmosis.
    Li J; Han Q; Gong P; Yang T; Ren B; Li S; Zhang X
    Vet Parasitol; 2012 Mar; 184(2-4):154-60. PubMed ID: 21906881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular characterization and protective immunity of rhoptry protein 35 (ROP35) of Toxoplasma gondii as a DNA vaccine.
    Zhang Z; Li Y; Liang Y; Wang S; Xie Q; Nan X; Li P; Hong G; Liu Q; Li X
    Vet Parasitol; 2018 Aug; 260():12-21. PubMed ID: 30197008
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c mice.
    Wang HL; Wen LM; Pei YJ; Wang F; Yin LT; Bai JZ; Guo R; Wang CF; Yin GR
    Parasite; 2016; 23():12. PubMed ID: 26984115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Granule-dependent killing of Toxoplasma gondii by CD8+ T cells.
    Nakano Y; Hisaeda H; Sakai T; Zhang M; Maekawa Y; Zhang T; Nishitani M; Ishikawa H; Himeno K
    Immunology; 2001 Nov; 104(3):289-98. PubMed ID: 11722643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice.
    Zhang NZ; Xu Y; Wang M; Petersen E; Chen J; Huang SY; Zhu XQ
    Expert Rev Vaccines; 2015; 14(9):1289-97. PubMed ID: 26111968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.